CYP2C9 c.169-1078C>T

Variant ID: 10-96700537-C-T

NM_000771.3(CYP2C9):c.169-1078C>T

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs2253635
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page



Polymorphisms in CYP2C9 are associated with response to indomethacin among neonates with patent ductus arteriosus.

Pediatric Research
Smith, Caitlin J CJ; Ryckman, Kelli K KK; Bahr, Timothy M TM; Dagle, John M JM
Publication Date: 2017-11

Variant appearance in text: rs2253635
PubMed Link: 28609430
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genetic markers in the EET metabolic pathway are associated with outcomes in patients with aneurysmal subarachnoid hemorrhage.

Journal Of Cerebral Blood Flow And Metabolism : Official Journal Of The International Society Of Cerebral Blood Flow And Metabolism
Donnelly, Mark K MK; Conley, Yvette P YP; Crago, Elizabeth A EA; Ren, Dianxu D; Sherwood, Paula R PR; Balzer, Jeffery R JR; Poloyac, Samuel M SM
Publication Date: 2015-02

Variant appearance in text: rs2253635
PubMed Link: 25388680
Variant Present in the following documents:
  • Main text
View BVdb publication page